Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Ipca Laboratories Limited, is a listed public company incorporated on 19 October, 1949. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 57.60 cr and the total paid-up capital is INR 25.37 cr.
Ipca Laboratories Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 26.67% over the previous year. At the same time, it's book networth has increased by 6.41%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Trusteeship Services Limited
No. of Loans: 2
Total Amount : 1,510.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 691.2 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 123.7 cr
JP Morgan Chase Bank N.A.
No. of Loans: 1
Total Amount : 114.2 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 29.7 cr
Canara Bank
No. of Loans: 16
Total Amount : 28.2 cr
ICICI BANKING CORPORATION LTD.
No. of Loans: 2
Total Amount : 20.0 cr
Export-Import Bank of India
No. of Loans: 2
Total Amount : 15.5 cr
EXPORT - IMPORT BANK OF INDIA
No. of Loans: 1
Total Amount : 4.5 cr
Union Bank of India
No. of Loans: 2
Total Amount : 2.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 1.4 cr
THE ICICI BANK LTD.
No. of Loans: 1
Total Amount : 1.0 cr
CITICORP FINANCE (INDIA) LTD.
No. of Loans: 1
Total Amount : 0.0 cr
MAHRASHTRA STATE FINANCIAL CORPORATION
No. of Loans: 1
Total Amount : 0.0 cr
Maharashtra State Financial Corporation
No. of Loans: 1
Total Amount : 0.0 cr
MERCATILE BANK LTD.
No. of Loans: 1
Total Amount : 0.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
CFO | Ajit Kumar Jain | <HIDDEN> | 11 years |
Managing Director | Ajit Kumar Jain
Shareholder
|
00012657 | 5 years |
Managing Director | Premchand Gigalal Godha
Shareholder
|
00012691 | 13 years |
Director | Prashant Premchand Godha
Shareholder
|
00012759 | 13 years |
Whole-time Director | Pranay Premchand Godha
Shareholder
|
00016525 | 16 years |
CS | Harish Pandurang Kamath
Shareholder
|
<HIDDEN> | 31 years |
Director | Kamal Kishore Seth
Shareholder
|
00194986 | 6 years |
Director | Vivek Keshav Shiralkar | 00340316 | 1 years |
Director | Narendra Mairpady | 00536905 | 2 years |
Director | Swati Arvind Patankar | 06594600 | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
IPCA FOUNDATION |
Active
|
0.0 | 3 | Maharashtra |
MEXIN MEDICAMENTS PRIVATE LIMITED |
Active
|
4.2 Cr | 3 | Maharashtra |
PRAYAS BIO LIFESCIENCE LIMITED |
Strike Off
|
10.0 L | 1 | Gujarat |
XGROW TRADERS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
5.0 L | 3 | Maharashtra |
JAIN INTERNATIONAL TRADE ORGANISATION |
Active
|
0.0 | 1 | Maharashtra |
KAYGEE LABORATORIES PRIVATE LIMITED |
Active
|
9.5 Cr | 3 | Maharashtra |
KAYGEE INVESTMENTS PRIVATE LIMITED |
Active
|
23.8 L | 3 | Maharashtra |
XBEES TRADERS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
5.0 L | 3 | Maharashtra |
HARLEYSTREET PHARMACEUTICALS LIMITED |
Amalgamated
|
95.2 L | 1 | Maharashtra |
PASCHIM CHEMICALS PRIVATE LIMITED |
Active
|
8.3 Cr | 2 | Maharashtra |
RESONANCE SPECIALTIES LIMITED |
Active
|
11.5 Cr | 1 | Maharashtra |
LYKA LABS LIMITED |
Active
|
36.8 Cr | 1 | Gujarat |
APSARA TREX PVT LTD |
Amalgamated
|
2.4 Cr | 1 | West Bengal |
XBEES TRADERS LLP |
Active
|
5.0 L | 2 | Maharashtra |
CAPRICOATING SOLUTIONS PRIVATE LIMITED |
Active
|
50.0 L | 1 | Dadra & Nagar Haveli |
MAKERS LABORATORIES LTD |
Active
|
5.9 Cr | 1 | Maharashtra |
UNICHEM LABORATORIES LIMITED |
Active
|
14.1 Cr | 1 | Maharashtra |
INDO-VIETNAMESE CHAMBER OF COMMERCE AND INDUSTRY |
Active
|
0.0 | 1 | Maharashtra |
GUFIC BIOSCIENCES LIMITED |
Active
|
10.0 Cr | 1 | Maharashtra |
OPEC INVESTMENT PVT LTD |
Active
|
1.0 L | 1 | Maharashtra |
KEWAL KIRAN CLOTHING LIMITED |
Active
|
61.6 Cr | 1 | Maharashtra |
KESAR ENTERPRISES LIMITED |
Active
|
10.1 Cr | 1 | Maharashtra |
VARDHMAN TRUSTEESHIP PRIVATE LIMITED |
Active
|
9.0 L | 1 | West Bengal |
VANAPRASTHA ASHRAM |
Active
|
0.0 | 1 | Tamil Nadu |
VISWAAT CHEMICALS LIMITED |
Active
|
5.0 Cr | 1 | Maharashtra |
MAHINDRA FIRST CHOICE WHEELS LIMITED |
Active
|
94.0 Cr | 1 | Maharashtra |
EQUIPPP SOCIAL IMPACT TECHNOLOGIES LIMITED |
Active
|
10.3 Cr | 1 | Telangana |
MAHINDRA RURAL HOUSING FINANCE LIMITED |
Active
|
122.9 Cr | 1 | Maharashtra |
MAN INDUSTRIES (INDIA) LIMITED |
Active
|
32.4 Cr | 1 | Maharashtra |
FIBRE FOILS LIMITED |
Active
|
5.5 Cr | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
TROPHIC WELLNESS PRIVATE LIMITED | Maharashtra | 2010 | ₹ 4.0 Cr |
Ipca Pharmaceuticals, Inc. USA | United States | - | - |
Ipca Laboratories (U.K.) Ltd. | United Kingdom | - | - |
Ipca Pharma Nigeria Ltd. | Nigeria | - | - |
Ipca Pharma (Australia) Pty. Ltd. | Australia | - | - |
Ipca Pharmaceuticals Ltd.,SA de CV | Mexico | - | - |
Onyx Scientific Ltd., UK | United Kingdom | - | - |
Ipca Pharma (NZ) Pty. Ltd. (Subsidiary of Ipca Pharma (Australia) Pty. Ltd.) | New Zealand | - | - |
Pisgah Labs Inc, USA (Subsidiary of Ipca Pharma,Inc. USA) | United States | - | - |
Bayshore Pharmaceuticals LLC, USA | United States | - | - |
The incorporation date of IPCA LABORATORIES LIMITED is 19 October, 1949
The authorized share capital of IPCA LABORATORIES LIMITED is INR ₹ 57.6 Cr.
The paid-up capital of IPCA LABORATORIES LIMITED is INR ₹ 25.4 Cr.
The registered address of IPCA LABORATORIES LIMITED is 48 KANDIVLI INDUSTRIALESTATE KANDIVALI (W) NA MUMBAI Maharashtra - 400067
The CIN number of IPCA LABORATORIES LIMITED is L24239MH1949PLC007837.